---All---
  • ---All---
  • Accession
  • Catalog #

PI3KCA Antibody (Center)Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP8016c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

PI3KCA Antibody (Center) - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP42336
Other AccessionQ14CW1
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW124284 Da

PI3KCA Antibody (Center) - Additional info

Gene ID 5290
Other Names
PIK3CA; Phosphatidylinositol 4, 5-bisphosphate 3-kinase catalytic subunit alpha isoform; Phosphatidylinositol 4, 5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha; Phosphoinositide-3-kinase catalytic alpha polypeptide; Serine/threonine protein kinase PIK3CA
Target/Specificity
This PI3KCA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 511~541 amino acids from the the center region of human PI3KCA.
Dilution
WB~~1:50~100
IHC~~1:50-100
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
PI3KCA Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

PI3KCA Antibody (Center) - Protein Information

Name PIK3CA
Function
Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns (Phosphatidylinositol), PtdIns4P (Phosphatidylinositol 4- phosphate) and PtdIns(4,5)P2 (Phosphatidylinositol 4,5- bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation in breast cancer cells through the PDPK1- AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway Has also serine-protein kinase activity: phosphorylates PIK3R1 (p85alpha regulatory subunit), EIF4EBP1 and HRAS

PI3KCA Antibody (Center) - Related products

AP8016c: PI3KCA Antibody (Center)

AP3558a: Phospho-PK3CA-pY317 Antibody

AP7860a: PK3CA Antibody (Y317)

AP8016a: PI3KCA Antibody (N-term)

AP8016b: PI3KCA Antibody (C-term)

RI13994: PIK3CA predesign siRNA

BP3558a: Phospho-PK3CA-pY317 Antibody Blocking Peptide

BP7860a: PK3CA Antibody (Y317) Blocking Peptide

BP8016a: PI3KCA Antibody (N-term) Blocking Peptide

BP8016b: PI3KCA Antibody (C-term) Blocking Peptide

BP8016c: PI3KCA Antibody (Center) Blocking Peptide

AJ1607a: PI3-kinase (p110) Antibody (subunit alpha)

AF1827a: PIK3CA / P110alpha Antibody

PI3KCA Antibody (Center) - Application data

  • Western blot analysis of anti-PIK3CA Antibody (Center) Pab (Cat.#AP8016c) in K562 cell line lysates (35ug/lane). PIK3CA (arrow) was detected using the purified Pab (1:60 dilution)

  • Western blot analysis of anti-PI3KCA Antibody (Center) Pab (Cat.#AP8016c) in 293 cell line lysates transiently transfected with the PIK3CA gene (1ug/lane). PI3KCA (arrow) was detected using the purified Pab (1:60 dilution).

  • Formalin-fixed and paraffin-embedded human breast carcinoma reacted with PI3KCA Antibody (Center)(Cat.#AP8016c), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

PI3KCA Antibody (Center) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers.

REFERENCES

Tiwari, S. Nat Immunol. August; 10(8): 907?17 (2009). Ballou, L.M., et al., J. Biol. Chem. 278(26):23472-23479 (2003). Singh, B., et al., Genes Dev. 16(8):984-993 (2002). Shayesteh, L., et al., Nat. Genet. 21(1):99-102 (1999). Volinia, S., et al., Genomics 24(3):472-477 (1994). Hiles, I.D., et al., Cell 70(3):419-429 (1992).